Jocelyn Beach, MD
Vascular Surgery · Lebanon, NHNPI 1437415478
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,295 of the $3,684 with a category attached, or 62.3%. 8 manufacturers reported payments, led by Stryker at 55.8% of the total. 2025 is the largest year on record at $2,056, 2.9 times the $697 reported in 2019.
Across 25 payments — averaging $147.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Silk Road Medical, Inc.$751
- W. L. Gore & Associates, Inc.$280
- Medtronic$172
- Inari Medical, Inc.$167
- Cook Medical LLC$146
- plus $111 from 2 others
What the payments were for
- Travel & lodging$2,29562%
- Food & beverage$1,38938%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 5 | $2,056 |
| Silk Road Medical, Inc. | 5 | $751 |
| W. L. Gore & Associates, Inc. | 4 | $280 |
| Medtronic(2 entities) | 4 | $172 |
| Inari Medical, Inc. | 2 | $167 |
| Cook Medical LLC | 3 | $146 |
| Siemens Medical Solutions USA, Inc. | 1 | $92 |
| Boston Scientific | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,684 in reported general payments places this provider in the 65th percentile of 43 vascular surgery providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 62 | $55,556 |
| EliquisApixaban | 18 | $7,897 |
| ClopidogrelClopidogrel Bisulfate | 53 | $868 |
| Atorvastatin Calcium | 32 | $426 |
| Rosuvastatin Calcium | 12 | $207 |
| Cilostazol | 12 | $187 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Lebanon
- Bjoern SuckowLebanon$101K
- Mark FillingerLebanon$26K
- Matthew AlefLebanon$25K
- Richard PowellLebanon$19K
- David KuwayamaLebanon$11K
- Brian NolanLebanon$8K
- Jessica WallaertLebanon$5K
- Jennifer StablefordLebanon$3K
- Nikolaos ZachariasLebanon$2K
- Amy FelstedLebanon$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.